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Objective: This study was performed to assess the prognostic value of serum hCG, progesterone, and inhibin A levels measured at 11 days post-
ET for predicting pregnancy outcome in women participating in IVF.
Methods: Between May 2005 and April 2008, sera were obtained from 70 infertile women who underwent IVF-ET at 11 days post-ET and stored. 
HCG, progesterone, and inhibin A levels were measured by commercial enzyme-linked immunosorbent assay kits. The predictive accuracy of 
hCG, progesterone, and inhibin A levels for establishment of intrauterine pregnancy and ongoing pregnancy was calculated by receiver-oper-
ating characteristic curve analysis.
Results: For the prediction of intrauterine and ongoing pregnancy, serum hCG was better than progesterone and inhibin A. The predictive per-
formance of progesterone and inhibin A was similar. The serum progesterone and inhibin A levels were significantly correlated each other (r= 
0.915, p=0.010).
Conclusion: A single measurement of the serum hCG level is sufficient to predict pregnancy outcome in IVF-ET patients. 
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Introduction
Pregnancies achieved by IVF-ET are at increased risk of adverse out-
comes compared with natural pregnancies or those achieved by ovum 
donation cycles [1]. Early pregnancy losses such as preclinical (chemi-
cal) and first trimester spontaneous abortions and ectopic pregnan-
cies are common during the first trimester. Thus, the prediction of 
early pregnancy outcome, especially at the time of pregnancy test-
ing, is of interest to many clinicians and infertile couples undergoing 
IVF-ET. Moreover, earlier diagnoses of complicated and poor preg-
nancy outcomes in patients that have undergone IVF would aid in 
counseling and management.
Ultrasound examination is part of the routine follow-up after IVF-
ET, but the gestational sac is reliably visible after the third week after 
ET. To confirm the establishment of pregnancy and forecast its out-
come at the earlier stage, research attempts have been made to iden-
tify serum biomarkers.
In practice, the initial establishment of pregnancy after ET is assessed 
by measuring serum hCG concentration which is reliable marker to 
forecast pregnancy outcome during the second week after ET. HCG is 
of placental origin, represents trophoblast functional integrity, and 
appears in maternal blood approximately 6 to 8 days after fertiliza-
tion. Numerous studies have revealed that pregnancies with low ini-
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tial hCG values are associated with a poor prognosis [2-6]. Serum hCG 
levels at 11 days post-ET are significantly lower for those that experi-
ence early pregnancy loss, and a cut-off of 50 mIU/mL was found to 
predict pregnancy outcome with good sensitivity and specificity of 
75% and 81%, respectively [4]. However, the positive predictive value 
(PPV) of hCG at this cut-off level was around 50% and its negative 
predictive value (NPV) was 93% in those study. However, in two re-
cent studies, with cut-off values of 80 and 76 mIU/mL, the PPV of 
hCG was 93.3% and 87% and NPV was 40% and 74%, respectively 
[2,3]. 
Since the corpus luteum is known to play an important role in early 
pregnancy, its activity could possibly be a marker of pregnancy out-
come [7-9]. Progesterone is produced and secreted by the corpus lu-
teum. Previous studies have revealed that progesterone is the most 
powerful single predictor of pregnancy outcome in natural concep-
tion [10,11]. However, the predictive role of progesterone in IVF preg-
nancy outcomes has been little studied and remains unproven [6,9].
Inhibins are gonadally-derived heterodimeric glycoproteins that 
are composed of an α and βA or βB, giving rise to inhibin A and inhibin 
B. Inhibins are produced and secreted by the corpus luteum [12] and/ 
or placenta [13] in early pregnancy. Maternal serum levels of inhibin 
A are higher during the first trimester of pregnancy than in nonpreg-
nant women [14]. The clearance of inhibin A is fast, with a short half-
life of 45 minutes [15]. 
In the present study, we investigated the role of progesterone and 
inhibin A measurement to discriminate among IVF pregnancy out-
comes and compared the predictive value of progesterone and in-
hibin A with that achieved with hCG.
Methods
1.	Patients
Between May 2005 and April 2008, sera were obtained and stored 
at the time of the pregnancy test (11 days post-ET) from 68 infertile 
women who underwent IVF-ET. The indications for IVF were tubal 
factor infertility (n=28), unexplained infertility (n=23), endometrio-
sis (n=8), male factor infertility (n=6), and advanced maternal age 
(n=3). All patients received progesterone (50 mg/day intramuscular-
ly, Watson Laboratories Inc., Morristown, NJ, USA) from the day of oo-
cyte pick-up (OPU). Serum hCG level was measured at 11 days post-
ET and the pregnancy outcomes were followed. This study was ap-
proved by the Institutional Review Board of Seoul National University 
Bundang Hospital (IRB No. B-1202-145-304).
2.	Hormone	assays
Serum hCG level was measured with a chemiluminescent micropar-
ticle immunoassay (Architect i2000, Abbott Laboratories, Abbott 
Park, IL, USA) for total beta-hCG. The measuring range for hCG was 
0.0 to 15,000 mIU/mL. Samples with hCG concentration >15,000 
mIU/mL were diluted using normal saline and multiplication was 
performed by the dilution factor. The intra- and inter-assay coeffi-
cient of variation (CV) were 1.2% to 4.7% and 1.6% to 4.9%, respec-
tively. 
Serum progesterone level measurement was performed using an 
electrochemiluminescence immunoassay (Elecsys Progesterone II; 
Hitachi High-technologies, Tokyo, Japan). The measuring range for 
progesterone was 0.03 to 60 ng/mL. Samples with progesterone con-
centration >60 ng/mL were diluted (1:10) using Elecsys Diluent Es-
tradiol/Progesterone, and multiplication was performed by the dilu-
tion factor. The intra- and inter-assay CV were 1.5% to 2.7% and 4.1% 
to 5.5%, respectively. 
Serum inhibin A was measured by a chemiluminescent immunoas-
say (Access Inhibin A; Beckman Coulter, Brea, CA, USA). The measur-
ing range for inhibin A was 1 to 1,500 pg/mL. Samples with inhibin A 
concentration >1,500 pg/mL were diluted using Access Sample Di-
luent A and multiplication was performed by the dilution factor. The 
intra- and inter-assay CV were 4.0% and 3.97%, respectively.
3.	Pregnancy	outcome
Establishment of pregnancy was defined by an hCG level above 10 
IU/L. Further classification of pregnancy outcomes was as follows: 
chemical pregnancy was defined as pregnancy detected by hCG mea-
surement, for which no gestational sac had been seen on ultrasound; 
ongoing pregnancy was defined as progression beyond 12 weeks’ 
gestation.
4.	Statistical	analysis
Data from 68 women were analyzed with SPSS ver.18 (SPSS Inc., 
Chicago, IL, USA) and MedCalc ver.12 (Medcalc Software, Mariakerke, 
Belgium). The Mann-Whitney U test was used for comparing contin-
uous variables between groups. To assess the predictive accuracy of 
hormonal levels and compare the predictive accuracy, receiver-oper-
ating characteristic (ROC) curves and comparison of ROC curves were 
used. Pearson’s correlation was used to examine the correlation be-
tween serum progesterone and inhibin A level. p-values <0.05 were 
considered statistically significant.
Results
Pregnancy outcomes were followed. The initial serum hCG titer was 
elevated in 29 women, but 11 women ended in chemical pregnancy. 
Intrauterine pregnancy was identified in 18 women. Among them, 
seven women experienced spontaneous miscarriage. 
The age of the women in the ongoing pregnancy group was signif-  http://dx.doi.org/10.5653/cerm.2012.39.1.28
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icantly lower when compared with the clinical abortion group (p= 
0.007), but the levels of the three serum markers in the two groups 
were similar (Table 1).
For the prediction of intrauterine pregnancy (clinical abortion+on-
going pregnancy), serum hCG (area under curve [AUC], 0.998; 95% 
confidence interval [CI], 0.000-1.000), progesterone (AUC, 0.767; 95% 
CI, 0.609-0.926) or inhibin A (AUC, 0.914; 95% CI, 0.834-0.986) was a 
significant predictor (Table 2). However, the predictive accuracy of 
serum hCG was better than that of progesterone (p=0.004) or inhib-
in A (p=0.024). The predictive accuracy of progesterone and inhibin 
A were similar (p=0.098). 
For the prediction of ongoing pregnancy, serum hCG (AUC, 0.971; 
95% CI, 0.000-1.000), progesterone (AUC, 0.732; 95% CI, 0.543-0.921), 
or inhibin A (AUC, 0.887; 95% CI, 0.806-0.967) was also a significant 
predictor. The predictive accuracy of serum hCG was better than pro-
gesterone (p=0.015) but similar to inhibin A (p=0.063). The predic-
tive accuracy of progesterone and inhibin A were similar (p=0.138). 
The serum progesterone and inhibin A levels were significantly cor-
related each other (r=0.915, p=0.010). 
Sub-group analysis was performed among 29 women in whom the 
serum hCG was above 10 IU/L. The pregnancy in these women fell 
into one of three outcomes: chemical (n=11), abortion (n=7), or on-
going pregnancy (n=11). To predict ongoing pregnancy, serum hCG 
(AUC, 0.909; 95% CI, 0.000-1.000) and inhibin A (AUC, 0.887; 95% CI, 
0.806-0.967) were significant predictors, but serum progesterone 
(AUC, 0.606; 95% CI, 0.388-0.825) was not. Serum hCG was superior 
to progesterone (p=0.015) but similar to inhibin A (p=0.070). The 
predictive accuracy of progesterone and inhibin A were similar (p= 
0.491).
 
Discussion
We investigated three serum markers to predict pregnancy out-
comes at the earliest stage. Like other studies, we found that the se-
rum hCG level measured at 11 days post-ET is the best and most reli-
able biomarker for predicting IVF pregnancy outcome. Serum pro-
gesterone and inhibin A measurement has predictive value but plays 
a more limited role compared to serum hCG in revealing IVF preg-
nancy outcomes. Therefore, routine assessment of serum progester-
one and inhibin A levels to predict pregnancy outcomes seems to be 
unwarranted. 
Ioannidis et al. [9] studied the value of progesterone for prediction 
of pregnancy outcome in IVF cycles. At day 14 after OPU, maternal 
serum progesterone levels were found to predict pregnancy outcome 
after IVF cycles. Women with ongoing pregnancies had significantly 
higher serum progesterone levels (median, 430 nmol/L) than those 
who had either an abnormal pregnancy, e.g., biochemical, miscarriage, 
or ectopic pregnancy (72 nmol/L) or failed to conceive (33 nmol/L). 
ROC analysis demonstrated that single serum progesterone on day 
14 post-OPU (at a cut-off of 103 nmol/L) could highly differentiate 
between normal and abnormal pregnancies (AUC, 0.927; 95% CI, 
0.89-0.96; sensitivity 88.2%, specificity 84%). This finding indicates 
that serum progesterone levels are significantly elevated and can be 
used to detect women destined to have viable intrauterine pregnan-
Table	1. Age and the level of serum markers according to pregnancy outcome
Non-pregnancy (n=39) Chemical pregnancy (n=11) Clinical abortion (n=7) Ongoing pregnancy (n=11)
Age of women 34.3±3.5 35.6±3.1 36.7±2.6 32.5±3.1
HCG (IU/L) 3.2±0.6 33.0±27.8 261.6±226.2 545.9±395.0
Progesterone (ng/mL) 25.9±14.2 39.5±23.3 105.6±97.2 74.3±56.4
Inhibin A (pg/mL) 5.1±3.6 37.5±63.6 146.9±153.1 122.7±115.3
Table	2. Efficiency of serum markers in predicting pregnancy outcomes
    Cut-off AUC (95% CI) Sens. (%) Spec. (%)
Overall (n=68) Intrauterine pregnancy HCG (IU/L) >107 0.998 (0.000-1.000) 88.9 100.0
Progesterone (ng/mL) >32.1 0.767 (0.609-0.926) 77.8 62.0
Inhibin A (pg/mL) >6.75 0.914 (0.843-0.986) 94.4 70.0
  Ongoing pregnancy HCG (IU/L) >129.0 0.971 (0.000-1.000) 100.0 93.0
Progesterone (ng/mL) >31.8 0.732 (0.543-0.921) 81.8 56.1
Inhibin A (pg/mL) >6.9 0.887 (0.806-0.967) 100.0 64.9
HCG>10 IU/L (n=29) Ongoing pregnancy HCG (IU/L) >159.5 0.909 (0.000-1.000) 100.0 83.3
Progesterone (ng/mL) >39.9 0.606 (0.388-0.825) 72.7 55.6
Inhibin A (pg/mL) >44.4 0.707 (0.520-0.894) 63.6 55.6
AUC, area under curve; Sens., sensitivity; Spec., specificity.www.eCERM.org
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cies despite exogenous progesterone supplementation.
However, the present study revealed that progesterone has little 
importance in predicting IVF pregnancy outcomes among serum 
biomarkers. Our findings were consistent with the results from a pre-
vious study [6]. Several reasons for the low predictive accuracy of 
progesterone in forecasting IVF pregnancy outcomes are possible. 
First, a small number of women was included in this study; thus it 
could not reach adequate power. Second, GnRH agonist or antago-
nist treatment may influence the production of progesterone from 
the corpus luteum. Third, exogenous progesterone for luteal support 
may affect the potential efficacy of serum progesterone in predicting 
outcomes. In our data, the progesterone level was higher than that 
of natural pregnancy in all pregnancy outcomes including non-preg-
nancy. Elevated serum progesterone due to exogenous progester-
one in the IVF cycle may decrease the predictive power of discrimi-
nating between ongoing pregnancies and clinical abortions. 
Initially low levels and a rapid decline of serum inhibin A concentra-
tions during the first trimester have been shown to be related to non-
viable pregnancies [16]. However, in a subsequent study, no signifi-
cant difference was found between serum inhibin A levels at day 16 
post-OPU in those with ongoing pregnancies and those that sponta-
neously aborted [8]. Nevertheless, inhibin A levels were shown to 
predict preclinical abortions after IVF [17]. Two recent reports indicat-
ed that inhibin A is superior to hCG for the prediction of preclinical 
abortion, but no significant differences were observed between the 
predictive values of hCG, inhibin A, or their combination in terms of 
differentiating between ongoing pregnancies and early pregnancy 
losses [8,17]. 
In this study, inhibin A level in the ongoing pregnancy group was 
not significantly different than that of the clinical abortion group 
(122.7±115.3 vs. 146.9±153.1). The cut-off level of inhibin A (AUC, 
0.914; 95% CI, 0.834-0.986) was 6.75 pg/mL for the prediction of in-
trauterine pregnancy, whereas for the prediction of ongoing preg-
nancy among women in whose pregnancy was established, the cut-
off level increased to 44.4 pg/mL and predictive accuracy decreased 
to 0.707. These findings suggest that a low level of inhibin A at the 
time of very early pregnancy indicates the likelihood of a poor out-
come, but forthcoming abortions are not predictable by early inhibin 
A measurement.
Serum concentrations of progesterone, estradiol, and hCG mea-
sured 12 to 13 days post-ET were found to be higher in an ongoing 
pregnancy group than in an abortion group [18]. However, the best 
predictor of ongoing pregnancy was found to be hCG concentration. 
Moreover, this multiple marker strategy was unhelpful in distinguish-
ing viable from non-viable pregnancies. 
Multiple hCG level measurements continue to be performed on IVF 
patients to monitor pregnancy progress. The prognostic values of 
single and paired measurements of serum hCG levels were analyzed 
in IVF setting [11,12]. An earlier report demonstrated that a single 
hCG determination on day 15 post-ET combined with the ratio of 
hCG on day 22 vs. day 15 has a higher diagnostic accuracy for pre-
dicting pregnancy outcome than absolute levels on either of these 
two days [19]. However, a recent report found that serial hCG mea-
surements do not contribute to the identification of non-ongoing 
pregnancies. A single hCG determination enabled approximately 
40% of non-viable pregnancies to be identified with a 85% positive 
predictive value, and the serial testing was found to have a 70% posi-
tive predictive value for identifying non-ongoing pregnancies [20].
We concluded that the serum hCG level is clinically valuable for fore-
casting pregnancy outcome after IVF-ET. Further research is needed 
to identify biomarkers discriminating ectopic pregnancies. 
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